Product List

Generic:

Rifaximin

Therapeutic Class:

Anti-Infective Antidiarrheal

Composition:

Each Zerifax tablet contains 200 mg or 550 mg of rifaximin

Description:

Zerifax tablet contain rifaximin, a non-aminoglycoside semi-synthetic, nonsystemic antibiotic derived from rifamycin. Rifaximin is a structural analog of rifampin

Indications:

ZERIFAX 200 mg is indicated for the treatment of patients (≥ 12 years of age) with travelers’ diarrhea caused by noninvasive strains of Escherichia coli.

Limitations of Use: ZERIFAX should not be used in patients with diarrhea complicated by fever or blood in the stool or diarrhea due to pathogens other  han Escherichiacoli.

Irritable Bowel Syndrome with Diarrhea: ZERIFAX is indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

Hepatic Encephalopathy: Zerifax 550 mg is indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients 18 years of age. 

Dosage:

Dosage for Travelers’ Diarrhea:

The recommended dose of ZERIFAX is one 200 mg tablet taken orally three times a day for 3 days. ZERIFAX can be administered orally, with or without food.

Dosage for Irritable Bowel Syndrome with Diarrhea: The recommended dose of ZERIFAX is one 550 mg tablet taken orally three times a day for 14 days. Patients who experience a recurrence of symptoms can be retreated up to two times with the same dosage regimen.

Dosage for Hepatic Encephalopathy:
The recommended dose of Zerifax is one 550 mg tablet taken orally two times a day, with or without food.

Presentations:

• Zerifax Tab 200 mg is available in pack of 10’s.
• Zerifax Tab 550 mg is available in pack of 10’s.